Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") has recently received notification that its Heparin Sodium Injection has obtained a drug registration certificate issued by the drug regulatory authority of Kyrgyzstan. The relevant details are announced as follows:
300255SZSE
Announcement on Heparin Sodium Injection Obtaining Drug Registration Certificate in Kyrgyzstan
✨ AI Summary
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. has received a drug registration certificate for its Heparin Sodium Injection from Kyrgyzstan's drug regulatory authority. This approval is expected to positively impact the company's expansion into overseas markets. Currently, overseas sales of heparin products represent a small portion of total revenue, and investors are advised to be cautious due to potential market risks.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.